Literature DB >> 2588206

Bronchiolitis obliterans organising pneumonia in patients taking acebutolol or amiodarone.

P Camus1, J N Lombard, M Perrichon, F Piard, J C Guérin, F B Thivolet, L Jeannin.   

Abstract

Two patients, treated with acebutolol and amiodarone respectively, developed a disease clinically, radiologically, and pathologically indistinguishable from bronchiolitis obliterans organising pneumonia. In one case recovery followed discontinuation of acebutolol; in the other case cessation of amiodarone had no effect, and corticosteroids were required. In addition to these patients, several cases of bronchiolitis obliterans organising pneumonia have been reported during treatment with gold salts, amiodarone, and miscellaneous other drugs. Taken together, this information supports the view that bronchiolitis obliterans organising pneumonia may be a form of response by the lungs to insult by drugs.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2588206      PMCID： PMC462050          DOI： 10.1136/thx.44.9.711

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  22 in total

1.  Pulmonary side effects after treatment with barbiturates.

Authors:  L Bense; L G Wiman; E Steiner; A Hjerpe
Journal:  Eur J Respir Dis       Date:  1986-07

2.  Free-base cocaine use associated with bronchiolitis obliterans organizing pneumonia.

Authors:  R C Patel; D Dutta; S A Schonfeld
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

3.  A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonia, and small airways disease.

Authors:  M L Guerry-Force; N L Müller; J L Wright; B Wiggs; C Coppin; P D Pare; J C Hogg
Journal:  Am Rev Respir Dis       Date:  1987-03

Review 4.  Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs.

Authors:  J A Cooper; D A White; R A Matthay
Journal:  Am Rev Respir Dis       Date:  1986-03

5.  Amiodarone pulmonary toxicity: clinical and subclinical features.

Authors:  P C Adams; G J Gibson; A R Morley; A J Wright; P A Corris; D S Reid; R W Campbell
Journal:  Q J Med       Date:  1986-05

6.  Amiodarone lung: pathologic findings in clinically toxic patients.

Authors:  J L Myers; J I Kennedy; V J Plumb
Journal:  Hum Pathol       Date:  1987-04       Impact factor: 3.466

7.  Lung biopsy in rheumatoid arthritis.

Authors:  S A Yousem; T V Colby; C B Carrington
Journal:  Am Rev Respir Dis       Date:  1985-05

8.  Radiographic manifestations of bronchiolitis obliterans with organizing pneumonia vs usual interstitial pneumonia.

Authors:  P W Chandler; M S Shin; S E Friedman; J L Myers; A L Katzenstein
Journal:  AJR Am J Roentgenol       Date:  1986-11       Impact factor: 3.959

9.  Pulmonary sequestration of amiodarone and desethylamiodarone.

Authors:  P Camus; H M Mehendale
Journal:  J Pharmacol Exp Ther       Date:  1986-06       Impact factor: 4.030

10.  Bronchiolitis obliterans and usual interstitial pneumonia. A comparative clinicopathologic study.

Authors:  A L Katzenstein; J L Myers; W D Prophet; L S Corley; M S Shin
Journal:  Am J Surg Pathol       Date:  1986-06       Impact factor: 6.394
View more
  11 in total

Review 1.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

2.  BOOP and COP.

Authors:  D M Geddes
Journal:  Thorax       Date:  1991-08       Impact factor: 9.139

Review 3.  Amiodarone-induced pulmonary toxicity. Predisposing factors, clinical symptoms and treatment.

Authors:  G A Jessurun; W G Boersma; H J Crijns
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

4.  [Medical therapy of heart and lung diseases. Effects on the respective other organ].

Authors:  S Möhlenkamp; G Weinreich; T Neumann; T Voshaar; H Teschler
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

Review 5.  Bronchiolitis obliterans with organising pneumonia: outcome.

Authors:  U Costabel; J Guzman; H Teschler
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

Review 6.  Amiodarone: review of pulmonary effects and toxicity.

Authors:  Spyros A Papiris; Christina Triantafillidou; Likurgos Kolilekas; Despoina Markoulaki; Effrosyni D Manali
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

Review 7.  Cryptogenic organizing pneumonia associated with invasive pulmonary aspergillosis: a case report and review of the literature.

Authors:  Shuanshuan Xie; Changxing Shen; Yunfeng Zhang; Kun Lu; Feng Hu; Min Tan; Haiyan Lin; Lei Xu; Qing Yuan; Xiaolian Song; Changhui Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

8.  Clinical spectrum of cryptogenic organising pneumonitis.

Authors:  R Bellomo; M Finlay; P McLaughlin; E Tai
Journal:  Thorax       Date:  1991-08       Impact factor: 9.139

Review 9.  Hemokinins and endokinins.

Authors:  N M Page
Journal:  Cell Mol Life Sci       Date:  2004-07       Impact factor: 9.261

10.  Nilutamide pneumonitis: a report on eight patients.

Authors:  P Pfitzenmeyer; P Foucher; F Piard; B Coudert; M L Braud; P Gabez; S Lacroix; J P Mabille; P Camus
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.